PRIMECAP MANAGEMENT CO/CA/ - Q4 2020 holdings

$135 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 319 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .

 Value Shares↓ Weighting
SGEN NewSEAGEN INC$941,012,0005,372,912
+100.0%
0.70%
MS NewMORGAN STANLEY$827,361,00012,072,976
+100.0%
0.62%
GS NewGOLDMAN SACHS GROUP INC$191,203,000725,050
+100.0%
0.14%
DASH NewDOORDASH INCcl a$62,302,000436,442
+100.0%
0.05%
FCX NewFREEPORT-MCMORAN INCcl b$62,503,0002,402,100
+100.0%
0.05%
LUNG NewPULMONX CORP$50,557,000732,500
+100.0%
0.04%
ALLO NewALLOGENE THERAPEUTICS INC$31,257,0001,238,400
+100.0%
0.02%
KEX NewKIRBY CORP$23,458,000452,600
+100.0%
0.02%
CVX NewCHEVRON CORP NEW$20,211,000239,330
+100.0%
0.02%
VLO NewVALERO ENERGY CORP$20,730,000366,441
+100.0%
0.02%
MASS New908 DEVICES INC$18,509,000325,000
+100.0%
0.01%
DOCU NewDOCUSIGN INC$8,970,00040,350
+100.0%
0.01%
WAT NewWATERS CORP$9,351,00037,795
+100.0%
0.01%
SKLZ NewSKILLZ INC$9,314,000465,700
+100.0%
0.01%
PEAK NewHEALTHPEAK PROPERTIES INC$5,169,000171,000
+100.0%
0.00%
SEER NewSEER INC$4,306,00076,700
+100.0%
0.00%
BYND NewBEYOND MEAT INC$2,725,00021,800
+100.0%
0.00%
SAFE NewSAFEHOLD INC$758,00010,450
+100.0%
0.00%
AVO NewMISSION PRODUCE INC$919,00061,090
+100.0%
0.00%
SIOX NewSIO GENE THERAPIES INC$146,00052,625
+100.0%
0.00%
TTWO NewTAKE-TWO INTERACTIVE SOFTWAR$353,0001,700
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LILLY ELI & CO42Q3 202310.5%
BIOGEN INC.42Q3 20236.8%
AMGEN INC.42Q3 20235.3%
MICROSOFT CORP.42Q3 20234.2%
ADOBE SYSTEMS INCORPORATED42Q3 20234.1%
TEXAS INSTRS. INC.42Q3 20233.5%
FEDEX CORP42Q3 20233.3%
SOUTHWEST AIRLS CO42Q3 20233.8%
NOVARTIS AG ADR42Q3 20232.7%
MICRON TECHNOLOGY INC42Q3 20232.8%

View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.

Latest significant ownerships (13-D/G)
PRIMECAP MANAGEMENT CO/CA/ Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NEKTAR THERAPEUTICSJuly 07, 20238,149,8764.3%
STANDARD BIOTOOLS INC.July 07, 20233,220,9174.1%
Calithera Biosciences, Inc.February 09, 2023401,0808.2%
CERUS CORPJanuary 09, 20238,849,6005.0%
COMSCORE, INC.January 09, 20232,883,4353.1%
STRATASYS LTD.December 08, 20223,176,4994.8%
Wave Life Sciences Ltd.December 08, 20224,225,9084.9%
NN INCNovember 09, 20221,763,6404.0%
AXCELIS TECHNOLOGIES INCOctober 07, 20221,649,4665.0%
Epizyme, Inc.Sold outSeptember 08, 202200.0%

View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-14
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12

View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.

Compare quarters

Export PRIMECAP MANAGEMENT CO/CA/'s holdings